Impact BioMedical introducse its executive leadership team, poised to lead the company through its next phase of innovation and growth. Frank D. Heuszel, CEO, brings experience in executive leadership, finance, and strategic planning to Impact BioMedical. Prior to joining DSS, Inc. as CEO in 2019, he had a successful career in commercial banking, serving in senior executive roles with major US and international banking organizations. Mark Suseck, COO, has been with Impact BioMedical since August 2023 and previously served as the COO of DSS BioHealth Holdings Inc., where he led company strategy, operations, licensing, acquisitions, and commercialization. Todd Macko joins Impact BioMedical as the CFO, while continuing to serve as CFO of DSS Inc. Mr. Macko has been with DSS since January 2021, initially serving as Secretary and Treasurer.